Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Theralase Technologies Inc.
TLTFF
Primary Symbol:
V.TLT
Healthcare
Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called...
Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.
see more
Get updates on Theralase Technologies Inc. delivered in your email.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
I consent to receiving electronic messages from Theralase Technologies Inc. and Stockhouse.
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Company Website
Add To Watchlist
Bullboard (TSXV:TLT)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(221)
•••
Alamir1111
X
View Profile
View Bullboard History
Comment by
Alamir1111
on Nov 20, 2024 6:48pm
RE:RE:RE:RE:RE:RE:RE:2025 Outlook
11000 volume. .285 c after 15 years of company existence boy that is a good stuff.Keep pumping boys
(1667)
•••
DJDawg
X
View Profile
View Bullboard History
Comment by
DJDawg
on Nov 20, 2024 6:45pm
RE:RE:RE:RE:Went back 17 pages on Dumbles post pages
Guys. Please. DDW has always been a "devil's advocate" type poster. He is who he is and we can read the posts or not. I really appreciate this forum when people share ideas, articles
...more
Pharmaceutical Tech Co Reports 2.7X Revenue Growth Year-Over-Year at US $24 Million
posted Nov 21, 2024 9:00am by
Innocan Pharma Corp
-
|
"Our strong operational and financial momentum continued throughout 2024 and now in the third quarter, we again demonstrated solid financial results. We are pleased to report nine consecutive quarters of continuous revenue growth. Our online platform continues to perform exceptionally well, contributing to our strong nine-month revenue growth of 174% YoY ...read more
(452)
•••
Dumbeldorfwhite
X
View Profile
View Bullboard History
Comment by
Dumbeldorfwhite
on Nov 20, 2024 6:41pm
RE:RE:RE:Went back 17 pages on Dumbles post pages
Look it's galaxies boyfriend here to save the day. You probably can't wait to meet up in Vegas.
(426)
•••
CAinPlap
X
View Profile
View Bullboard History
Comment by
CAinPlap
on Nov 20, 2024 5:43pm
RE:RE:Went back 17 pages on Dumbles post pages
What's the matter? Don't like being exposed? Normal investors would also post on a forum of a stock they were invested in. #weirdos spend all their free time posting on a forum of a stock they
...more
(441)
•••
BlueFranky
X
View Profile
View Bullboard History
Comment by
BlueFranky
on Nov 20, 2024 5:33pm
RE:RE:RE:RE:RE:RE:2025 Outlook
Damn it Cancer Slayer, you never cease to provide this board with unbiased clarity and dare I say, hope. Thanks once again for all of your efforts!
(187)
•••
reconsider
X
View Profile
View Bullboard History
Post by
reconsider
on Nov 20, 2024 5:31pm
Bullish pennant resolving on Friday-Monday
TLTFF 4h chart
(1192)
•••
CancerSlayer
X
View Profile
View Bullboard History
Comment by
CancerSlayer
on Nov 20, 2024 4:58pm
RE:RE:RE:RE:RE:2025 Outlook
IP currently constitutes the main value of this company, especially if we attain a BTD (bigger bargaining chip). In order to better protect that IP, I'd rather see this company find a
...more
(0)
•••
ElBorto
X
View Profile
View Bullboard History
Comment by
ElBorto
on Nov 20, 2024 4:57pm
RE:RE:RE:RE:RE:RE:RE:RE:RE:2025 Outlook
Apparently I don't know how to post links here. Tips are welcomed https://theralase.com/wp-content/uploads/2024/10/Theralase-Corporate-Presentation-10-15-2024-2.pdf
(0)
•••
ElBorto
X
View Profile
View Bullboard History
Comment by
ElBorto
on Nov 20, 2024 4:55pm
RE:RE:RE:RE:RE:RE:RE:RE:2025 Outlook
So far it looks like the side effects are less concerning than other non-FDA approved drugs. Slide 22 of their corporate presentation looks promising. [url=https://https://theralase.com/wp-content
...more
(452)
•••
Dumbeldorfwhite
X
View Profile
View Bullboard History
Comment by
Dumbeldorfwhite
on Nov 20, 2024 4:43pm
RE:Went back 17 pages on Dumbles post pages
Sounds like you have way too much free time. Talk about a stalker, I feel bad for whoever you ve dated in the past #weirdo
(467)
•••
rollthedice10
X
View Profile
View Bullboard History
Comment by
rollthedice10
on Nov 20, 2024 3:02pm
RE:Pfizer has a new man in oncology so TLT could be a great pic
This could very well be a good thing for TLT. Pfizer needs to get some new drugs to market. And the new guy will want to produce. New guy was in charge of oncology.. Hmmm Cancer drugs are likely
...more
(544)
•••
riverrrow
X
View Profile
View Bullboard History
Comment by
riverrrow
on Nov 20, 2024 2:08pm
RE:RE:RE:RE:RE:RE:RE:2025 Outlook
You conveniently forgot to mention that the CR for the 12 underdosed patients was actually pretty good. And if a patient in the trial dies because he was in a car accident does it matter to the
...more
(567)
•••
Galaxym31
X
View Profile
View Bullboard History
Post by
Galaxym31
on Nov 20, 2024 2:04pm
Went back 17 pages on Dumbles post pages
nothing but TLT. A focused basher indeed.
(537)
•••
O12009
X
View Profile
View Bullboard History
Post by
O12009
on Nov 20, 2024 1:49pm
Pfizer has a new man in oncology so TLT could be a great pic
Pfizer, under pressure to change, names oncology head as new R&D chiefhttps://www.biopharmadive.com/news/pfizer-chris-boshoff-cso-research-development-dolsten-successor/733433/?utm_source=Sailthru
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Discover Options Trading Strategies to Minimize your Tax Burden